Interleukin-2 therapy of cancer

Related Experiment Video

Updated: Aug 22, 2026

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

J Bubeník1

  • 1Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Prague, Czech Republic. bubenik@img.cas.cz

Folia Biologica
|September 18, 2004
PubMed

Insights

This review assesses two decades of Interleukin-2 (IL-2) cancer therapy, examining preclinical results for clinical translation. It also explores IL-2 gene-modified vaccines and discusses the future of IL-2 treatments.

Area of Science:

  • Immunotherapy
  • Oncology
  • Gene Therapy

Background:

  • Interleukin-2 (IL-2) has been investigated for cancer treatment for over twenty years.
  • Preclinical studies have explored various IL-2 administration methods, including local, systemic, and adjuvant approaches.

Purpose of the Study:

  • To evaluate the clinical translatability of preclinical IL-2 therapy findings.
  • To review the development and application of IL-2 gene-modified tumor vaccines.
  • To discuss the prospects and limitations of IL-2-based therapies and gene therapies.

Main Methods:

  • Systematic review of published literature on IL-2 cancer therapy.
  • Analysis of preclinical models and clinical trial data.
  • Evaluation of gene-modification techniques for IL-2 delivery.

Main Results:

  • Significant progress has been made in understanding IL-2's mechanisms in cancer.
  • Certain preclinical results show promise for clinical application, but challenges remain.
  • IL-2 gene-modified vaccines represent a novel therapeutic strategy with potential.

Conclusions:

  • Translating preclinical IL-2 therapy results into effective clinical treatments requires further research.
  • IL-2 gene therapy offers a promising avenue, but its full potential and limitations need thorough investigation.
  • A balanced assessment of IL-2 therapy and gene therapy is crucial for advancing cancer treatment.

More Related Videos

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles09:57

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...